Nevro (NYSE:NVRO – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Tuesday, August 6th. Analysts expect Nevro to post earnings of ($0.63) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
Nevro (NYSE:NVRO – Get Free Report) last announced its earnings results on Tuesday, May 7th. The medical equipment provider reported ($0.70) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.02) by $0.32. Nevro had a negative return on equity of 27.48% and a negative net margin of 19.17%. The firm had revenue of $101.90 million during the quarter, compared to analyst estimates of $97.90 million. During the same period last year, the firm posted ($0.98) EPS. The business’s revenue was up 5.8% compared to the same quarter last year. On average, analysts expect Nevro to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Nevro Trading Down 1.4 %
Shares of NVRO opened at $9.05 on Monday. The business has a 50-day moving average of $9.07 and a 200 day moving average of $12.29. Nevro has a fifty-two week low of $7.46 and a fifty-two week high of $22.64. The firm has a market cap of $332.41 million, a P/E ratio of -3.95 and a beta of 0.91. The company has a debt-to-equity ratio of 0.77, a quick ratio of 5.57 and a current ratio of 7.38.
Wall Street Analyst Weigh In
Get Our Latest Research Report on NVRO
About Nevro
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems.
Recommended Stories
- Five stocks we like better than Nevro
- What is MarketRank™? How to Use it
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- What is the Nikkei 225 index?
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Best Stocks Under $5.00
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Nevro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nevro and related companies with MarketBeat.com's FREE daily email newsletter.